Sarah-Meryll BUET


From a financial background, Meryll started her career in capital markets between London & Paris. She has developed a passion for Sciences & Innovation. After having helped to develop Alkion BioPharma, she wants to build a new Greentech innovation's trajectory with Alkion BioInnovations.


General Manager

Franck holds a Civil Engineering degree and a MBA in Finance & Economics. From Investment Banker to Biotech risk taker, Franck is active in Biotechnologies as investor/business developer. He leads Alkion's operational and financial activities. 

Dr. Julien SECHET


Julien holds a PhD in plant physiology from AgroParisTech and INRAE. Constantly intrigued by the beauty of plant structures, Julien has built an expertise in plant development and physiology learned during his PostDoc in Berkeley and INRAE. Following an academic path focused on the biosynthesis and signaling of plant hormones and cell wall metabolites, he leads today the R&D team in Alkion and handles bioengineering and analyical tolls to push plants break their limits.

Dr. Houssein WEHBI

Plant tissue researcher

Houssein holds a PhD in Plant Biotechnology from University of Paris Saclay and INRAE. He brings us his deep expertise in plant tissue culture and embryogenesis.

Dr. Franck MICHOUX


He is the co-inventor of Alkion's patented technology, AlkaBurst.

He has developed & commercialised the cosmetic application of the technology with new large scale bioreactors.   


He holds a PhD in Molecular & Cellular Biology from Imperial Innovations London.

He has 2 patents on his credit.

Dr. Peter NIXON


Peter is Professor of Biochemistry at Imperial College London & in collaboration with Nanyang Technological University (Singapore). His team is studying various aspects of solar energy conversion by chloroplasts and cyanobacteria. Peter is a world expert on chloroplast transformation and has realized major works on the subject. He advises Alkion on pharmaceutical projects. 


Rep. Imperial Innovations (Partner)

Govind leads the Co.Create team within the Technology Transfer team dedicated to entrepreneurship at Imperial Innovations Ltd. In his early career Govind was a scientist at the Cavendish labs in Cambridge University and in Japan. Govind has a BSc in Chemical Physics from University of Sussex, PhD in Semiconductor Physics from University of Warwick and an MBA from Imperial College business school.


Dr. Norbert Winhab

VP Strategic Project Health Care - Evonik Industries AG

Dr. Norbert Windhab is heading the function Strategic Projects at Evonik Industries AG Business Line Health Care since 2008. He spun out the JV from Aventis SA with Nanogen Inc., CA, in the field of DNA-based diagnostics and drug-research as its Managing Director in 2001 and entered Degussa AG, now Evonik Industries in 2005 to initiate clinical programs in nutraceutical product innovation and novel functional drug delivery excipients.

Dr. Windhab is scientific board member at the University of Freiburg BIOSS Government Excellence Center and in the Kuratorium of the Max Planck Institute in Cologne. He is lecturer Pharma Polymers at the University of Jena and invited auditor to Fraunhofer Institutes. 

He was R&D head “Bioorganic Systems” at Aventis R&T from 1998 until 2001. In 1996 he became project director chip-diagnostics at Hoechst AG’s R&T central research. In 1994 he joined Albert Eschenmoser’s laboratories (ETH-Zürich/ Scripps Institute, La Jolla CA) for post-doctoral research. He obtained his PhD in Biophysical Chemistry at the Freiburg University in 1993 on the synthesis and bio-physical properties of bio-polymers and RNA model compounds. He was member of the scientific advisory board of the venture fund Polytechnos II in Munich until 2005. 


He published scientific and strategic articles and holds numerous patents in peptide actives chemistry, drug R&D and delivery technology in the fields of life-sciences, supra-molecular chemistry and biopolymers. 


Colin Stott

C.O.O Alinova Biosciences Ltd

Colin is co-founder of the new Venture Alinova Biosciences Ltd.

He spent 18 years as Head of Operational R&D at GW Pharm to develop medical cannabis cultivation.  


He holds a BSc in Medicinal & Pharmaceutical Chemistry from Loughborough University.